Maven Securities’s Wave Life Sciences WVE Stock Holding History

Maven Securities’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-35,000	Closed	-$283K	–	992
2025 Q1	$283K	Sell	35,000 -135,000	-79%	-$1.48M	0.01%	720
2024 Q4	$2.1M	Sell	170,000 -680,000	-80%	-$9.08M	0.05%	275
2024 Q3	$6.97M	Buy	+850,000	New	+$5.08M	0.14%	128
2024 Q1	–	Sell	-1,452,778	Closed	-$7.34M	–	1025
2023 Q4	$7.34M	Buy	+1,452,778	New	+$7.76M	0.15%	103
2021 Q3	–	Sell	-311,768	Closed	-$2.08M	–	1293
2021 Q2	$2.08M	Sell	311,768 -52,418	-14%	-$343K	0.08%	226
2021 Q1	$2.04M	Buy	364,186 +334,186	+1,114%	+$3.21M	0.09%	218
2020 Q4	$236K	Buy	+30,000	New	+$252K	0.02%	477

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Maven Securities's WVE Position: Q2 2025 in Review

Maven Securities sold out of Wave Life Sciences (WVE) in Q2 2025, closing a stake of 35,000 shares — an estimated $283K sold.

Maven Securities first reported a position in WVE in Q4 2020 and held it in 7 quarters. The position peaked at $7.34M in Q4 2023. 176 funds tracked by Wall St. Rank hold WVE as of Q2 2025.

Maven Securities reported no remaining Wave Life Sciences position as of Q2 2025 after selling out during the quarter.
Maven Securities sold 35,000 Wave Life Sciences shares in Q2 2025, an estimated $283K.
Maven Securities first reported a position in Wave Life Sciences in Q4 2020 and held it in 7 quarters.
Maven Securities's Wave Life Sciences position peaked at $7.34M in Q4 2023.
176 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.